America February 9, 2026
Eli Lilly to Buy Orna Therapeutics in $2.4B RNA Bet
In a move that underscores Big Pharma’s race to harness next-generation genetic medicine, Eli Lilly to buy Orna Therapeutics in…
America February 9, 2026
In a move that underscores Big Pharma’s race to harness next-generation genetic medicine, Eli Lilly to buy Orna Therapeutics in…
By Rachel Moore
America February 9, 2026
Emerging from a year marked by budget cuts and leadership upheaval, the University of Nebraska new AI Institute is staking…
By Rihem Akkouche
America February 9, 2026
In a bold bid to reshape Britain’s wealth landscape, NatWest to acquire Evelyn Partners for £2.7 billion ($3.7 billion), tightening…
By Rihem Akkouche
America February 9, 2026
In a calculated move aimed at sharpening its healthcare focus, GBL invests in Rayner, agreeing to acquire a 45% stake…
By Rihem Akkouche
America February 9, 2026
In a dramatic turn for a brand long associated with rugged peaks and expedition parkas, Eddie Bauer files Chapter 11…
By Rihem Akkouche
America February 9, 2026
A once-rebranded blockchain finance firm now finds itself navigating the unforgiving terrain of bankruptcy court. Archblock filed for Chapter 11…
By Rihem Akkouche
America February 9, 2026
In a sweeping move that redraws the landscape of Britain’s eldercare market, Safanad Sells HC-One for more than $1.6 billion,…
By Rihem Akkouche
America February 6, 2026
The Federal Trade Commission has thrown a regulatory wrench into the semiconductor industry’s latest blockbuster: FTC $22B Chip Giant merger…
By Rachel Moore
America February 6, 2026
In a move underscoring Wall Street’s deepening wager on climate-resilient infrastructure, TPG Acquires Stake in Sabre Industries, taking a majority…
By Rachel Moore
America February 6, 2026
In a move that signals a strategic reshuffling in the global spirits market, Kirin to sell Bourbon Brand Four Roses…
By Rachel Moore